glp 1 agonist heart disease Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology Diabetic Agents, From Metformin to

Several of the PGDPs have important and well-defined (pharmacological) effects on systemic metabolism, including the modulation of food intake and satiety (GLP-1, glucagon, oxyntomodulin), regulation of fluid homeostasis (water intake and urine excretion) (GLP-1) [92], thermogenesis (glucagon), lipid metabolism (GLP-1, glucagon, GLP-2), gastrointestinal motility (glucagon, GLP-1, GLP-2), and gastric emptying (glucagon, GLP-1, GLP-2)

But thats being evaluated in a lot of research right now. Will older people in Colorado qualify for Medicare GLP-1 weight loss drugs

Association of GLP-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases

Scheme 13

They work through integrated actions on your pancreas, gut-brain axis and multiple organs including the liver, heart, kidney and brain